Skip to content

Effect of Air-tamponade on Intraretinal Cystoid Changes After Membrane Peeling

Effect of Air-tamponade on Intraretinal Cystoid Changes After Vitrectomy With Membrane Peeling

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03457584
Enrollment
96
Registered
2018-03-07
Start date
2017-11-01
Completion date
2019-12-01
Last updated
2020-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epiretinal Membrane

Brief summary

Patients with intraretinal cystoid changes before scheduled membrane peeling for epiretinal membranes are included. Patients are randomized for balanced salt solution (BSS) or air-tamponade.

Detailed description

Patients with intraretinal cystoid changes before scheduled membrane peeling for epiretinal membranes are included. 23G-pars plana vitrectomy with membrane peeling is performed in all patients. Before surgery patients are randomized for BSS or air-tamponade. Optical coherence tomography (OCT) is performed 5 days after and 3 months after surgery, visual acuity is measured 3 months after surgery.

Interventions

PROCEDUREair arm

epiretinal membranes are excised during membrane peeling and air-tamponade is left in the eye

PROCEDUREBSS arm

epiretinal membranes are excised during membrane Peeling and BSS is left in the eye

Sponsors

Vienna Institute for Research in Ocular Surgery
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* epiretinal membranes and intraretinal cystoid changes

Exclusion criteria

* macular edema due to other reason than epiretinal membrane * hereditary ocular disease * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
resorption of intraretinal cystoid changes after surgery3 monthsoccurrence of intraretinal cystoid changes will be diagnosed by OCT

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026